Artisan Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,837,924
| Closed | -$23.7M | – | 307 |
|
|
2023
Q1 | $23.7M | Sell |
2,837,924
-40,503
| -1% | -$338K | 0.04% | 246 |
|
|
2022
Q4 | $33M | Buy |
2,878,427
+228,811
| +9% | +$2.63M | 0.06% | 234 |
|
|
2022
Q3 | $33.4M | Sell |
2,649,616
-267,593
| -9% | -$3.37M | 0.06% | 232 |
|
|
2022
Q2 | $30.9M | Buy |
2,917,209
+75,804
| +3% | +$802K | 0.05% | 235 |
|
|
2022
Q1 | $46.2M | Buy |
2,841,405
+175
| +0% | +$2.85K | 0.06% | 235 |
|
|
2021
Q4 | $39.4M | Sell |
2,841,230
-10,154
| -0.4% | -$141K | 0.05% | 262 |
|
|
2021
Q3 | $41M | Sell |
2,851,384
-292,101
| -9% | -$4.2M | 0.05% | 254 |
|
|
2021
Q2 | $49.7M | Buy |
3,143,485
+117,879
| +4% | +$1.86M | 0.06% | 237 |
|
|
2021
Q1 | $30.8M | Buy |
+3,025,606
| New | +$30.8M | 0.04% | 275 |
|